Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the company will be held on Thursday 29th July 2021, to consider and approve unaudited consolidated and standalone financial results of the Company for the first quarter ended 30th June 2021.
The above information is a part of company’s filings submitted to BSE.